Comparative study of expression of hemagglutinins, hemolysins, and enterotoxins by clinical and environmental isolates of non-O1 Vibrio cholerae in relation to their enteropathogenicity by Datta-Roy, K. et al.
Vol. 52, No. 4APPLIED AND ENVIRONMENTAL MICROBIOLOGY, OCt. 1986, p. 875-879
0099-2240/86/100875-05$02.00/0
Copyright C 1986, American Society for Microbiology
Comparative Study of Expression of Hemagglutinins, Hemolysins,
and Enterotoxins by Clinical and Environmental Isolates of Non-Ol
Vibrio cholerae in Relation to Their Enteropathogenicity
KRISHNA DATTA-ROY,1 KALYAN BANERJEE,1 S. P. DE,2 AND ASOKE C. GHOSEL*
Departments ofImmunologyl and Microbiology,2 National Institute of Cholera and Enteric Diseases (Indian Council of
Medical Research), Beliaghata, Calcutta-700 010, India
Received 18 February 1986/Accepted 8 July 1986
A comparative study was undertaken of clinical and environmental isolates of non-O1 Vibrio chokrae with
respect to their hemagglutinating, hemolytic, enterotoxigenic, and enteropathogenic activities. Cell-associated
hemagglutinin titers of the clinical and environmental isolates did not differ much, although the clinical isolates
displayed higher cell-free hemagglutinin titers compared with those of environmental isolates. Culture
supernatants of 61.5% (24 of 39) of clinical isolates showed hemolytic activity (-10% lysis of rabbit
erythrocytes), while only 33.3% (10 of 30) of the environmental group had such activity. Furthermore,
hemolytic activities of the clinical isolates showed a good correlation with their cell-associated hemagglutinin
titers which was not true for the environmental group. Culture supernatants of 45.8% (11 of 24) of the clinical
and 20% (2 of 10) of the environmental isolates exhibited enterotoxigenic activity in the rabbit ileal loop assay.
Such activity was mediated mainly by cholera toxin-like substances, although some of the isolates produced
fluid-accumulating factors unrelated to cholera toxin. Experimental animal studies demonstrated that the
enteropathogenic potential of the environmental isolates was significantly lower than that of the clinical group.
Further analysis of our data showed that phenotypic expression of cholera toxin-like products by the non-O1
V. cholerae isolates was accompanied by their enteropathogenicity. The latter effect was also noted with some
of the cholera toxin-negative isolates, particularly in those having high hemagglutinating and hemolytic titers.
Vibrio cholerae organisms of non-O1 serotypes are widely
distributed in the aquatic environment and are free-living in
nature (2, 28). Unlike V. cholerae 01, they do not usually
have epidemic or pandemic potential (2). However, they
have often been identified as the causative agents of sporadic
cases (12, 16, 22) and localized outbreaks (1, 4, 29) of
choleralike diarrhea which is sometimes accompanied by
fever, blood, and mucus (4, 12). The severity of non-O1
diarrhea is of lesser magnitude compared with that of V.
cholerae 01 (21). Apart from their diarrheagenic potential,
these organisms have also been implicated in a few cases of
extraintestinal infections (2, 12).
A good number of V. cholerae non-O1 isolates produce
cholera toxin (CT)-like toxins (13, 19, 23, 31-33) although the
majority do not. Apart from CT-like toxins, production of
other kinds of factors responsible for fluid accumulation
(FA) or enteritis by non-O1 strains has also been docu-
mented (11, 14, 15, 17, 18, 21, 22, 25, 26). Furthermore, they
express certain other biologically active factors such as
hemagglutinins (8, 10) and hemolysins (28) which may have
some role in the expression of their pathogenicity. However,
the relative importance of these putative virulence factors is
still obscure. Moreover, it is not yet clear why clinical cases
of diarrhea produced by non-O1 V. cholerae are rarely
encountered despite the widespread occurrence of these
organisms in the environment.
In the present communication, we made a comparative
study of several clinical and environmental isolates of non-
01 V. cholerae with respect to their hemagglutinin, hemo-
lysin, and CT-like toxin production capacities. We also tried
to determine whether any of these properties either singly or
in combination can be related to the enteropathogenic po-
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tential of the organisms as determined in the experimental
animal models.
MATERIALS AND METHODS
Bacterial strains. The clinical strains of non-O1 V. chol-
erae used in this study were isolated in this Institute,
essentially as pure cultures from the stool samples of diarA,
rheal patients. Two of the clinical strains were kindly sup-
plied by R. Sakazaki (Tokyo, Japan), while seven other
strains were supplied by H. L. Smith (Philadelphia, Pa.).
The environmental non-O1 V. cholerae strains were isolated
from the water and sediments of local (Calcutta) ponds and
the Hooghly River. All the strains were characterized by
routine bacteriological tests carried out in the Microbiology
Department of our Institute. Some of the strains could be
serotyped by the antisera kindly supplied by R. Sakazaki.
Strains supplied by H. L. Smith had already been typed in
his laboratory.
Determination of CAHA titer. V. cholerae non-O1 strains
were grown in nutrient agar slants for 18 h at 37°C. Cells
were harvested by washing twice with cold normal saline
and centrifugation (5,000 x g) and finally suspended in
Krebs-Ringer-Tris buffer (KRT), pH 7.4. The concentration
of the bacterial suspension was adjusted to 600 Klett units.
The cell-associated hemagglutinin (CAHA) titer was deter-
mined against a mouse erythrocyte suspension (2.5% in
KRT) as described by Dasgupta et al. (6). CAHA activities
of some of the strains were also determined against chicken,
rabbit, and human erythrocytes.
Determination of CFHA titer. Bacterial strains were grown
in 50 ml of tryptic soy broth (Difco Laboratories, Detroit,
Mich.) in 250-ml Erlenmeyer flasks for 18 h at 370C while.1
shaking. The culture was centrifuged at 14,000 x g for 30
min, and the supernatant was passed through a Millipore
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filter paper (0.45-,um pore size). Next, the cell-free culture
supernatant was made 50% saturated with (NH4)2SO4, and
the mixture was kept overnight at 4°C. The precipitate was
centrifuged at 16,000 x g for 15 min. The pellet was
dissolved in the minimum volume of distilled water and
dialyzed against KRT buffer. The dialyzed material was
centrifuged, and the clear supernatant was appropriately
diluted (10- to 15-fold) with the same buffer to give a protein
concentration of 50 ,ug/ml. Hemagglutinin titers of these
cell-free preparations were determined against a 2.5% mouse
erythrocyte suspension as described previously (6). Cell-free
hemagglutinin (CFHA) activities were also determined
against chicken, rabbit, and human erythrocytes.
Determination of hemolytic activity. For the determination
of cell-free hemolytic activity, bacteria were grown in brain
heart infusion broth for 24 h at 37°C while shaking. The
culture was centrifuged at 14,000 x g for 15 min, and the
supernatant was collected. A 1-ml sample of this supernatant
was mixed with 1 ml of 1% rabbit erythrocyte suspension in
phosphate-buffered saline, pH 7.2. The mixture was incu-
bated for 1 h at 37°C. Next, it was centrifuged at 200 x g for
2 min, and the supernatant was collected. The amount of
lysis was determined by measuring the A540 of the superna-
tant. Finally, results were expressed as the percentage of
lysis by comparing these optical density values with that of
an identical erythrocyte suspension lysed (100%) with an
equal volume of distilled water. Cell-free hemolytic activities
of some of the non-O1 strains were also determined against
chicken, mouse, and human erythrocytes in the same way as
described above.
Determination of enterotoxic activity. Enterotoxin produc-
tion capacity of the non-O1 V. cholerae strains was deter-
mined by the rabbit ileal loop (RIL) method (7) and the
staphylococcal coagglutination (COA) test (20).
For the RIL test, bacteria were grown in brain heart
infusion broth for 18 h at 37°C with shaking, and cell-free
culture supernatant (1 ml) was injected into the ligated ileal
loops of a rabbit. After 18 to 20 h, the rabbit was sacrificed
and the accumulated fluid volume was measured. Results
were expressed as the FA ratio (fluid volume in milliliters per
loop length in centimeters). The culture supernatant of each
of the bacterial strains was tested twice in two separate
rabbits, and the mean of the two values was recorded.
For the COA test, COA reagent was prepared by essen-
tially following the methodology of Ronnberg and Wadstrom
(20). Rabbit antiserum against purified CT (Schwarz/Mann,
Orangeburg, N.Y.) was raised in the laboratory and diluted
fourfold to coat Staphylococcus aureus Cowan I cells. This
dilution was found to be the optimum when prechecked with
positive (purified CT at appropriate dilutions) and negative
(uninoculated broth) controls. Non-O1 strains were grown in
syncase broth (3) supplemented with lincomycin (100 ,ug/ml)
at 30°C for 18 h without shaking (23). Cell-free culture
supernatants were obtained by centrifugation at 14,000 x g
for 30 min and passed through Millipore filter paper (0.45-,um
pore size). The COA test was done on a glass slide by adding
25 ,u1 of the culture filtrate to 25 ,ul of the COA reagent.
Determination of pathogenicity. (i) RIL method. Ligated
ileal loops of rabbits were challenged with 0.5 ml of whole
cultures of bacteria (109 cells per ml) grown in brain heart
infusion broth for 18 h. The FA ratio was determined by the
same procedure as described above.
(ii) The infant mouse model. Pathogenicity of some of the
non-O1 V. cholerae strains was also determined in the infant
mouse model (27). For this, laboratory-bred 4- to 5-day-old
Swiss albino mice of both sexes were orally challenged with
0.1 ml of the bacterial suspension (109 cells per ml) in 0.1%
Proteose Peptone (Difco Laboratories, Detroit, Mich.)-
saline containing 0.01% Evan's blue. Bacteria were grown
earlier in nutrient agar slant cultures for 18 h at 37°C and
harvested. Groups of five mice were used for each bacterial
strain. Results were scored by determining the number of
diarrheagenic deaths in each group of mice within 24 h of
challenge. A control group of mice received 0.1 ml of
Proteose Peptone-saline with dye only. A hypertoxigenic
strain of V. cholerae 01 (569B Inaba) was used as the
positive control.
RESULTS
Hemagglutinating activity. CAHA titers of 32 clinical and
22 environmental V. cholerae non-Ol strains were deter-
mined against mouse erythrocytes. It was found that CAHA
titers (reciprocal) varied considerably and ranged from c2 to
256. However, no marked difference could be noted between
the clinical and environmental isolates with respect to their
CAHA titers. Furthermore, comparable titers were obtained
when some of the strains from both the groups were tested
against chicken, human, and rabbit erythrocytes.
Seven clinical and three environmental isolates were also
tested for their ability to produce CFHA. Interestingly, six
of seven clinical and all three environmental isolates showed
this activity against mouse erythrocytes, with titers ranging
between 4 and 128 for the clinical isolates and 4 and 8 for the
environmental samples. Comparable titers were obtained
with rabbit erythrocytes. CFHA titers were, however, very
weak or absent (titer of c4) for these strains against chicken
and human erythrocytes.
Hemolytic activities. Hemolytic activities of 39 clinical and
30 environmental isolates were determined against rabbit
erythrocytes. The hemolytic activities of strains belonging to
both groups were found to vary considerably. However, a
greater percentage of clinical isolates (61.5%) showed hemo-
lytic activities above 10%, while only 33.3% of all the
environmental isolates had such activities. Three clinical
strains had very high hemolytic activities (80 to 100%), while
none of the environmental strains belonged to this group.
Hemolytic activities of some of these strains against eryth-
rocytes of other species followed the order: rabbit > mouse
> chicken > human.
Correlation of CAHA titers with hemolytic activities.
CAHA titers of the 32 clinical and 22 environmental non-O1
isolates were plotted separately against their corresponding
hemolytic activities (Fig. 1). Statistical analysis (5) of the
data shows that the Spearman's rank correlation coefficient
(rp) between these two parameters for the clinical isolates is
0.58 and that this value is statistically significant (P < 0.001).
On the other hand, rp for the environmental samples is 0.36,
which is not statistically significant (P > 0.05).
Enterotoxin production. (i) Culture supernatants of 11 of 24
(45.8%) clinical and 2 of 10 (20%) environmental strains gave
positive ileal loop reactions (FA ratio, -0.3). However, FA
ratios were comparatively higher for clinical isolates (rang-
ing between 0.34 and 1.05 with a mean value of 0.59) than for
environmental isolates (ranging between 0.40 and 0.45 with a
mean value of 0.43). (ii) Culture supernatants of 9 of 24
(37.5%) clinical and only 1 of 10 (10%) environmental strains
gave positive COA reactions. In all cases, the positive COA
reaction could be blocked by prior incubation of the culture
supernatants with rabbit anti-CT serum.
Pathogenicity test. A total of 24 clinical and 10 environ-
mental strains were tested for their diarrheagenic potential in
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the ligated ileal loops of rabbits (Table 1). All of the 24
clinical and 7 of 10 environmental strains showed positive
loop reactions (FA ratio, -0.4). However, the reactivities of
the clinical isolates were stronger than those of environmen-
tal ones, and this difference was statistically significant as
determined by Student's t test (0.05 > P > 0.01).
Seven clinical and seven environmental non-O1 isolates
were tested for their enteropathogenic potential in the infant
mouse model (Table 2). The table also includes the
serotypes, CAHA, CFHA, and hemolytic activities of these
strains as well as their enterotoxin production capacities.
These strains are also shown in Fig. 1 as filled circles. Of
seven clinical isolates, six induced .60% diarrheagenic
death within 24 h of challenge, whereas only two of seven
environmental strains showed similar mortality rates. Mor-
tality rates in mice challenged with the rest of the environ-
mental strains varied considerably (0 to 40%).
DISCUSSION
Results presented in this study show that V. cholerae
strains of non-O1 serotypes possess considerable amounts of
CAHA, CFHA, and hemolytic activities. In fact, the CAHA
titer ranges were comparable to those of V. cholerae 01
(ElTor) strains as reported earlier from this laboratory (6). It
may be mentioned here that this is probably the first report
which convincingly demonstrates the release of soluble
hemagglutinin in the cell-free culture supernatants of non-O1
strains. However, CFHA activity showed some degree of
species specificity and was demonstrable mainly against
mouse and rabbit but not human or chicken erythrocytes. A
high percentage of non-O1 strains also showed hemolytic
activities toward rabbit and, to a lesser extent, mouse
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FIG. 1. Correlation between CAHA titers and hemolytic activi-
ties of 32 clinical (A) and 22 environmental (B) isolates of non-01 V.
cholerae. Filled circles represent isolates used for detailed study as
presented in Table 2.
TABLE 1. Enteropathogenicity of whole cultures of non-01 V.
cholerae isolates in the RIL model
No. of No of FA ratio (ml/cm)Source isolateSa positive Statisicd
reactionsb Range Mean' ± SD analysis
Clinical 24 24 0.4-1.1 0.61 ± 0.18 t = 2.28
Environ- 10 7 0.4-0.5 0.46 ± 0.01 0.05 > P >
mental 0.01
a The same isolates were used for these experiments as well as for studying
enterotoxin production abilities in the RIL model and COA test.
b FA ratio, - 0.4.
c Mean of positive reactions only.
d Done by Student's t test.
erythrocytes. Such activity was very weak, if present at all,
against chicken and human erythrocytes. Similar results
were also reported from the study of a non-O1 hemolysin by
Yamamoto et al. (30), who, however, did not report any
hemagglutinating activity in their system.
Results presented here (Table 2) failed to show any
absolute correlation between CAHA and hemolytic titers
and virulence of non-O1 isolates. This was true for isolates
belonging to clinical as well as environmental groups. Fur-
thermore, no significant difference in the CAHA titers be-
tween the clinical and the environmental isolates could be
seen. However, a higher percentage of the clinical isolates
(61.5%) had more than 10% of hemolytic activity compared
with 33.3% of the environmental ones. Another interesting
observation was that the CAHA titers of clinical isolates
showed some correlation with their corresponding hemolytic
activities, which was not true for the environmental group.
The exact significance of these observations is not clear at
present. V. cholerae 01 strains are known to express more
than one kind of CAHA (8, 9). It is quite possible that the
non-O1 strains also follow the same rule and that one of
these hemagglutinins is probably related to its hemolytic
activity. The clinical strains, for some reason yet unknown,
may express more of the latter type of CAHA related to the
hemolysin.
A high percentage of clinical isolates (45.8%) showed
enterotoxin production activity in their culture supernatant
which induced FA in the ligated ileal loops in rabbits. The
fact that the majority of these reactions were mediated by
the CT-like toxin is supported by the results of the COA test.
Interestingly, supernatants of four clinical and one environ-
mental isolates gave positive loop reactions but a negative
COA test, thereby suggesting the presence of FA factors
unrelated to CT. In fact, the culture supernatant of one
(clinical) of these five isolates was subsequently found to
produce heat-stable enterotoxinlike activity in the suckling
mouse assay (K. Datta-Roy and A. C. Ghose, unpublished
observation). Release of non-CT-like FA factor by non-O1
vibrios has already been documented by other workers (11,
14, 15, 17, 18, 21, 22, 25, 26), although its biochemical
identity has yet to be clearly established. It was further
noted that culture filtrates of two of the clinical isolates failed
to induce FA in the RIL experiments, while giving positive
reactions in the COA test. It is possible that supplementation
of the culture medium with lincomycin, coupled with the
higher sensitivity of the COA test (3), led to the detection of
CT production by these hypotoxigenic strains.
That non-O1 strains can cause enteritis even in the ab-
sence of CT production is evident from our experimental
animal studies. In fact, all the 24 clinical strains and a large
percentage of the environmental strains (70%) induced FA in
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TABLE 2. Expression of hemagglutinins, hemolysins, enterotoxins, and enteropathogenicity by some clinical and environmental isolates
of non-O1 V. cholerae
RIL expt Suckling
COA % CAHA CFHA (FA ratio)a museStrain Source Serotype reaction Hemolysis titer titer Whole Culture test
culture filtrate mortalityb
V2 Clinical 37 (Sak)c + 100 256 128 0.95 1.0 4/5
V5 Clinical 6 (Sak) + 1 2 0 1.1 1.05 3/5
10357 Clinical 2 (Sm)d - 52 64 4 0.73 e 3/5
9829 Clinical 11 (Sm) - 23 16 NDf 0.65 2/5
9627 Clinical 34 (Sak) + 52 8 ND 0.52 3/5
S22 Clinical 34 (Sak) - 40 64 ND 0.65 3/5
10259 Clinical 59 (Sm) + 4 8 4 0.9 0.65 3/5
58N Environmental NT9 - 3 0 ND ND ND 0/5
N70 Environmental 6 (Sak) - 45 128 ND 0.5 4/5
N75 Environmental NT - 31 16 ND 0.45 1/5
N38 Environmental 14 (Sak) - 2 8 ND h 0/5
N76 Environmental 6 (Sak) + 10 256 ND 0.4 0.45 3/5
N100 Environmental 52 (Sak) - 3 4 ND 0.46 2/5
N5 Environmental 37 (Sak) - 8 64 ND - 1/5
Saline 0/5
569B 01 1.5 1.1 5/5
Inaba
a Mean values of FA ratios obtained from two different rabbits.
b Ratio of the number of dead/number of challenged animals.
c Sakazaki serotype.
d Smith serotype.
eFA ratio was considered to be negative (<0.3).
f ND, Not done.
8 NT, Not typable by Sakazaki serotyping system.
hFA ratio, .0.4.
the ligated ileal loops of rabbits (Table 1). However, the
diarrheagenic potential was significantly lower in the envi-
ronmental group compared with the clinical group. These
results agreed reasonably well with those obtained with the
infant mouse model (Table 2), in which the diarrheagenic
mortality rate was considerably higher for the clinical than
for the environmental group. Spira and co-workers (21, 22)
in their studies with non-O1 V. cholerae strains showed that
a greater proportion ofhuman isolates possessed enteropath-
ogenic potential compared with isolates obtained from the
aquatic environment. They also noted that enterotoxin pro-
duction was not common among their environmental iso-
lates.
The parameters which determine the enteropathogenic
{otential of V. cholerae non-O1 strains are yet to be defined.
*Nowever, it is evident from the results presented in Table 2
that of the various parameters examined in this study,
phenotypic expression of CT-like toxin by the non-O1 V.
cholerae strains was accompanied by their entero-
pathogenicity. Such enteropathogenicity was also noted with
some of the non-CT-producing strains, particularly in those
having higher hemagglutinating and hemolytic titers. The
precise role of the hemagglutinins and hemolysins in the
'pathogenic process remains to be defined. In a recent report,
Spita et al. (24) suggested that colonization factors of non-O1
strains play a critical role in the determination of their
pathogenicity and that environmental strains were more
poorly colonizing than the clinical ones. Therefore, it would
be of considerable interest to define more specifically the
biochemical nature of such putative factors responsible for
adhesion and colonization and to establish their relationship,
if any, with the hemagglutinins or hemolysins or both. Such
studies are under way.
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